Toxin tied to deadly staph pneumonia under the microscope

NCT ID NCT02798497

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study looked at 234 patients with severe staph pneumonia to see if a toxin called PVL makes the disease worse. Researchers compared survival rates between patients infected with PVL-producing bacteria and those without. They also collected blood samples to explore whether genetics play a role in how sick people get.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict which patients with staph pneumonia are at highest risk and guide treatment decisions.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not change current medical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS PNEUMONIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia staphylococcal infection staphylococcal pneumonia staphylococcus aureus pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre National de Références des Staphylocoques Centre de Biologie et Pathologie Est 59 bd Pinel

    Bron, 69677, France